Rejoyn™
Rejoyn™ is made and published by Otsuka Precision Health, Inc. AppBrain is an independent app data site and isn't affiliated with Otsuka Precision Health, Inc. The app name, icon, screenshots and description belong to Otsuka Precision Health, Inc. and are shown as published on the App Store.
AppBrain's verdict
- Rating on App Store
- 3.80
- 30 ratings
- Last updated
- September 24, 2026
- Size
- 323.1 MB
It doesn't have enough ratings yet to judge what users think.
User feedback
Ratings and reviews on the App StoreComments on Rejoyn™ for iOS
We don't have enough comments to show example comments. Please check back later.
Store listing
By Otsuka Precision Health, Inc., from the App StoreDescription by Otsuka Precision Health, Inc. Written by the developer, not by AppBrain. Click to read.
The brain-training exercises in Rejoyn were developed and studied by a team of psychologists, psychiatrists, and neuroscientists. In a clinical trial, adding Rejoyn to antidepressant medication reduced depression symptoms with zero side effects related to Rejoyn. The exercises and lessons in Rejoyn tap into the brain's natural ability to change, known as neuroplasticity. You can think of it like physical therapy, but for your brain. Using Rejoyn for less than 2 hours per week for 6 weeks is designed to change how the brain works, which can improve depression symptoms.
Interested in trying Rejoyn?
Rejoyn must be prescribed by a healthcare provider. Talk to your provider about Rejoyn or learn how you can consult with a provider online at www.rejoyn.com.
Already have a prescription?
Download the app to get started. Once Rejoyn is downloaded, the app will guide you through setting up your account.
For more information, visit www.rejoyn.com.
See Patient Instructions for Use at https://www.rejoyn.com/Patient-Instructions-for-Use.pdf.
INDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.
SAFETY INFORMATION: Rejoyn is not intended to be used as a standalone treatment. Rejoyn does not replace your current medication, including medication for treatment of MDD. You should continue your current treatment as directed by your healthcare provider.
Rejoyn cannot send alerts or warnings to your healthcare provider. If you feel that your depression symptoms are worsening or if you have feelings or thoughts of harming yourself or others, please contact your healthcare provider, dial 911, or go to the nearest emergency room immediately.
To review the developer’s Privacy Policy, visit www.rejoyn.com/App-Privacy-Policy.
© 2024 Otsuka Precision Health, Inc. All rights reserved.
August 2024 20US23EBC0053
Safety and technology
Found in the app by AppBrain- Price
- Free
- App size
- 323.1 MB
- Content rating
- High
Technologies used by Rejoyn™
Releases
Updates seen on the App Store- Version
- 1.11.0
- Launched
- August 2024
No changelog data
Alternatives
Similar apps and more from Otsuka Precision Health, Inc.Rankings
App Store top chartsApp Store Rankings for Rejoyn™
About the app and developer
About Rejoyn™
Rejoyn™ is a medical app developed by Otsuka Precision Health, Inc.
User Ratings
Rejoyn™ is rated 3.80 out of 5 stars. The rating is based on 30 ratings.
App Information
Rejoyn™ is freely available from the App Store. The app size is 323.06 MB. The latest version available is 1.11.0. The last update was on September 24, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since August 2024.
Developer information for Otsuka Precision Health, Inc.
Address: